[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334053-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334053-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-imaging-biomarkers-for-early-cancer-detection-a-systematic-review-of-emerging-technologies-and-clinical-applications","Molecular Imaging Biomarkers for Early Cancer Detection - A Systematic Review of Emerging Technologies and Clinical Applications","","Early cancer detection is crucial for improving patient outcomes, and molecular imaging biomarkers enable non-invasive diagnosis in early stages. The objective evaluates the effectiveness and accuracy of these biomarkers across imaging modalities and cancer types. A comprehensive search of major databases (PubMed/MEDLINE, Embase, Web of Science, Cochrane Library, Scopus) from January 2010 to December 2023 was conducted, using QUADAS-2 for risk of bias and narrative synthesis with quantitative analysis when applicable. Fifty studies were included, with PET-based biomarkers showing high sensitivity and specificity, while novel tracers and optical intraoperative imaging demonstrated promising performance. Conclusions support clinical integration with further work on standardization and cost-effectiveness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-imaging-biomarkers-for-early-cancer-detection-a-systematic-review-of-emerging-technologies-and-clinical-applications/334053/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-imaging-biomarkers-for-early-cancer-detection-a-systematic-review-of-emerging-technologies-and-clinical-applications/334053.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of evaluating molecular imaging biomarkers in this systematic review?","Question",{"text":63,"@type":64},"To assess the effectiveness and accuracy of molecular imaging biomarkers for early cancer detection across different imaging modalities and cancer types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases and time range were used to identify eligible studies?",{"text":68,"@type":64},"The review searched PubMed/MEDLINE, Embase, Web of Science, Cochrane Library, and Scopus from January 2010 to December 2023.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding PET-based biomarkers?",{"text":72,"@type":64},"PET-based biomarkers showed the highest sensitivity (mean 89.5%) and specificity (mean 91.2%), with promising results for novel tracers such as [68Ga]-PSMA and [18F]-FES.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334053,1790165265,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Systematic Review  \nMolecular Imaging Biomarkers for Early Cancer Detection: A Systematic Review of Emerging Technologies and Clinical Applications  \nMaajid Mohi Ud Din Malik 1, Mansour M. Alqahtani 2, Ibrahim Hadadi 3, *, Ibrahem Kanbayti 4, Zeyad Alawaji 5 and Bader A. Aloufi 6  \nCitation: Malik, M.M.U.D.; Alqahtani, M.M.; Hadadi, I.; Kanbayti, I.; Alawaji, Z.; Aloufi, B.A. Molecular Imaging Biomarkers for Early Cancer Detection: A Systematic Review of Emerging Technologies and Clinical Applications. Diagnostics 2024, 14, 2459. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)diagnostics14212459  \nAcademic Editor: Giorgio Treglia  \nReceived: 9 September 2024  \nRevised: 23 October 2024  \nAccepted: 29 October 2024  \nPublished: 3 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Dr. D.Y. Patil School of Allied Health Sciences, Dr. D.Y. Patil Vidyapeeth,(Deemed to be University) Sant Tukaram Nagar, Pune 411018, MH, India; [maajid.malik@dpu.edu.in](maajid.malik@dpu.edu.in)  \n2 Department of Radiological Sciences, College of Applied Medical Sciences, Najran University, Najran 61441, Saudi Arabia; [mmalqahtane@nu.edu.sa](mmalqahtane@nu.edu.sa)  \n3 Department of Radiological Sciences, College of Applied Medical Sciences, King Khalid University, Asir, Abha 62529, Saudi Arabia  \n4 Radiologic Sciences Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [ikanbayti@kau.edu.sa](ikanbayti@kau.edu.sa)  \n5 Department of Radiologic Technology, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia; [z.alawaji@qu.edu.sa](z.alawaji@qu.edu.sa)  \n6 Department of Diagnostic Radiology, College of Applied Medical Sciences, Taibah University, Madinah 42353, Saudi Arabia; [baoufi@taibahu.edu.sa](baoufi@taibahu.edu.sa)  \n* Correspondence: [ihadadi@kku.edu.sa](ihadadi@kku.edu.sa)  \nAbstract: Background: Early cancer detection is crucial for improving patient outcomes. Molecular imaging biomarkers offer the potential for non-invasive, early-stage cancer diagnosis. Objectives: To evaluate the effectiveness and accuracy of molecular imaging biomarkers for early cancer detection across various imaging modalities and cancer types. Methods: A comprehensive search of PubMed/MEDLINE, Embase, Web of Science, Cochrane Library, and Scopus was performed, covering the period from January 2010 to December 2023 . Eligibility criteria included original research articles published in English on molecular imaging biomarkers for early cancer detection in humans. The risk of bias for included studies was evaluated using the QUADAS-2 tool. The findings were synthesized through narrative synthesis, with quantitative analysis conducted where applicable. Results: In total, 50 studies were included. Positron emission tomography (PET)-based biomarkers showed the highest sensitivity (mean: 89.5%, range: 82–96%) and specificity (mean: 91.2%, range: 85–100%) . Novel tracers such as [68Ga]-PSMA for prostate cancer and [18F]-FES for breast cancer demonstrated promising outcomes. Optical imaging techniques showed high specificity in intraoperative settings. Conclusions: Molecular imaging biomarkers show significant potential for improving early cancer detection. Integration into clinical practice could lead to earlier interventions and improved outcomes. Further research is needed to address standardization and cost-effectiveness.  \nKeywords: molecular imaging biomarkers; early cancer detection; PET/SPECT imaging; cancer screening; personalized oncology  \n1. Introduction  \nCancer remains one of the leading health threats in modern society globally, wi","cbCainglIwxhsXlM","https://ap.wps.com/l/cbCainglIwxhsXlM","pdf",1368747,24,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main purpose of evaluating molecular imaging biomarkers in this systematic review?\",\"answer\":\"To assess the effectiveness and accuracy of molecular imaging biomarkers for early cancer detection across different imaging modalities and cancer types.\"},{\"question\":\"Which databases and time range were used to identify eligible studies?\",\"answer\":\"The review searched PubMed/MEDLINE, Embase, Web of Science, Cochrane Library, and Scopus from January 2010 to December 2023.\"},{\"question\":\"What were the key findings regarding PET-based biomarkers?\",\"answer\":\"PET-based biomarkers showed the highest sensitivity (mean 89.5%) and specificity (mean 91.2%), with promising results for novel tracers such as [68Ga]-PSMA and [18F]-FES.\"}]","Molecular Imaging Biomarkers for Early Cancer Detection - A Systematic Review of Emerging Technologies and Clinical Applications | PDF",1790005146]